Profile
Robert Diepold served as Co-Chief Executive Officer at IBL International GmbH in 2009.
Prior to that, he was Managing Director at Spreewald-Pharma GmbH, Spreewälder Spezialitäten GmbH, and Pharmasan GmbH Freiburg from 2001 to 2005.
He also served as Executive Vice President-Sales at Fresenius SE & Co. KGaA in 2001 and as Principal at Beiersdorf AG from 1988 to 1998.
Diepold holds a doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and another doctorate degree from Madison University.
Former positions of Robert Diepold
| Companies | Position | End |
|---|---|---|
| Spreewald-Pharma GmbH | President | 2004-12-31 |
| Spreewälder Spezialitäten GmbH | President | 2004-12-31 |
| Pharmasan GmbH Freiburg | President | 2004-12-31 |
| FRESENIUS SE & CO. KGAA | Sales & Marketing | 2000-12-31 |
| BEIERSDORF | Corporate Officer/Principal | 1997-12-31 |
Training of Robert Diepold
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
| Madison University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FRESENIUS SE & CO. KGAA | Health Technology |
| BEIERSDORF | Consumer Non-Durables |
| Private companies | 4 |
|---|---|
IBL International GmbH
 IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Commercial Services |
| Spreewald-Pharma GmbH | |
| Spreewälder Spezialitäten GmbH | |
| Pharmasan GmbH Freiburg | Process Industries |
- Stock Market
- Insiders
- Robert Diepold
